Local players to continue domination in anti-fungal drug market in India: F&S
With fast-paced advancements in technology, the number of patients diagnosed with systemic fungal infections (SFIs) is expected to increase steadily over the next five years, says a new analysis from Frost & Sullivan entitled Systemic Fungal Infection Therapeutics Market – India.
.png){kind=small}
